Forward-Looking Statements

Statements made in, or accessible through this page, regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding Replimune ability to successfully initiate and complete clinical trials and development programs, the expected timing for reporting of top-line data, Replimune ability to obtain regulatory approval, market penetration and acceptance of any of it’s products and the initiation of clinical studies. Risks that contribute to the uncertain nature of the forward-looking statements include: Replimune future preclinical studies and clinical trials may not be successful; changes in regulatory requirements in the United States and foreign countries may prevent or significantly delay regulatory approval of Replimune products; Replimune may change its plans to develop and commercialize its product candidates; the FDA may not agree with Replimune interpretation of the data from clinical trials; Replimune may decide, or the FDA may require Replimune, to conduct additional clinical trials or to modify Replimune clinical trials; Replimune may experience delays in the commencement, enrollment, completion or analysis of clinical testing for its product candidates, or significant issues regarding the adequacy of its clinical trial designs or the execution of its clinical trials, which could result in increased costs and delays, or limit Replimune ability to obtain regulatory approval; the third parties with whom Replimune has partnered with for the development of its products and upon whom Replimune relies to conduct its clinical trials and manufacture its product candidates may not perform as expected; Replimune may not receive regulatory approval for its products or be successfully commercialized; unexpected adverse side effects or inadequate therapeutic efficacy of any of its products could delay or prevent regulatory approval or commercialization; Replimune may be unable to obtain and maintain intellectual property protection for its product candidates; the loss of key scientific or management personnel; Replimune ability to obtain additional financing; and the accuracy of Replimune estimates regarding expenses, future revenues and capital requirements. All forward-looking statements contained in this presentation speak only as of the date on which they were made. Replimune undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Disclaimer

THE INFORMATION ON THIS WEBSITE IS PROVIDED “AS IS” WITHOUT ANY WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. ALTHOUGH Replimune WILL USE REASONABLE EFFORTS TO INCLUDE UP-TO-DATE AND ACCURATE INFORMATION ON THIS WEBSITE, Replimune MAKES NO REPRESENTATIONS, WARRANTIES, OR ASSURANCES THAT THE INFORMATION ON THIS WEBSITE IS OR WILL BE TIMELY, ERROR-FREE, OR COMPLETE.

NEITHER Replimune NOR ANY OTHER PARTY INVOLVED IN CREATING THIS WEBSITE IS LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES (INCLUDING DAMAGES FOR LOSS OF BUSINESS, LOSS OF USE, LOSS OF PROFITS, LITIGATION, OR THE LIKE) ARISING OUT OF YOUR ACCESS TO, INABILITY TO ACCESS, OR USE OF THIS WEBSITE, OR FROM YOUR RELIANCE ON ANY INFORMATION PROVIDED ON THIS WEBSITE, INCLUDING BUT NOT LIMITED TO AS A RESULT OF ANY BUGS OR VIRUSES THAT MAY INFECT YOUR COMPUTER PROGRAMS OR EQUIPMENT. THE FOREGOING EXCLUSION OF LOSSES AND DAMAGES SHALL APPLY WHETHER A CLAIM IS BASED ON BREACH OF CONTRACT, BREACH OF WARRANTY, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY, OR OTHERWISE, AND EVEN IF Replimune IS OR SHOULD BE AWARE OF THE POSSIBILITY OF SUCH DAMAGES.

Trademarks and Copyright

Unauthorized use of any Replimune trademark, service mark, or logo may be a violation of federal and state trademark laws.

This website is protected by U.S. and foreign copyright laws. Except for your informational, personal, non-commercial use, as authorized above, you may not modify, reproduce, or distribute the design or layout of the website, individual sections of the design or layout of the website, or Replimune logos without our written permission.

Links to Other Sites

Replimune may make available to the visitor links to third-party websites over which Replimune has no control. Replimune has not reviewed the sites that may be linked to this website, and does not endorse and is not responsible for the content of any other sites. Other sites may be inaccurate or contain discussions regarding unapproved uses of drugs, medical devices, or other products. Your linking to such sites is at your own risk, and Replimune shall not be liable for any damage or injury arising from their content or your use thereof.

Visitor Communications and Security

Any communications you send to this website or otherwise to Replimune electronically will not be considered proprietary to you and will be received on a nonconfidential basis. Replimune is under no obligation to refrain from reproducing, publishing, or otherwise using your communications in any way or for any purpose. You hereby grant to Replimune your consent to use your communications. Without compensation to you or any other person, Replimune shall own and be free to use any such communications, including ideas, inventions, concepts, techniques, improvements, or know-how disclosed therein, for any purpose including without limitation, developing, manufacturing, and/or marketing products and services.

You are responsible for maintaining appropriate security for your computer system. Replimune may employ cookie technology to, among other things, allow users to move more quickly through the site. Cookies are small files a website can use to recognize repeat users and facilitate the user’s ongoing access to and use of the site. Generally, cookies work by assigning a unique number to the user that has no meaning outside the assigning site. Users should be aware that Replimune cannot control the use of cookies by third parties.

Health Information

Replimune is not engaged in rendering medical, healthcare, or other professional advice.

This website may contain information on medical and health-related topics. This information, including any product data, is for informational purposes only and is not intended to describe or make claims about the safety or efficacy of any product. This information is also not meant to be a substitute for the advice provided by your own physician or other medical professional, and you should not use this information for diagnosing or treating a health problem or disease. You should always consult your own physician before undertaking or changing any medical treatment, drug therapy, or healthcare activities.

Update Policy

Information prepared by Replimune that is accessible through this site is current only as of the date that it was prepared. This information may be incomplete or may have become out of date. Replimune makes no commitment and disclaims any duty to update such information.

Trademarks

All Replimune brand and product names are trademarks or registered trademarks of Replimune Pharmaceuticals in the United States and other countries.Replimune collects information online to enhance your use of our website, to determine what products and services you desire (we currently do not sell any products or services), to provide you requested customer services, to allow you convenient access to our current products and services and to make our future products and services available to you.